{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T20:28:39Z","timestamp":1775420919897,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.urolonc.2021.09.018","type":"journal-article","created":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T01:59:58Z","timestamp":1636163998000},"page":"109.e21-109.e30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2251-3379","authenticated-orcid":false,"given":"Che Hsueh","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8844-4882","authenticated-orcid":false,"given":"Wei Chun","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-7231","authenticated-orcid":false,"given":"Yen Chuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-0036","authenticated-orcid":false,"given":"Yi Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4337-7230","authenticated-orcid":false,"given":"Li Hua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3707-6423","authenticated-orcid":false,"given":"Chin Heng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang Yi","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9809-7442","authenticated-orcid":false,"given":"Chao Yu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-7613","authenticated-orcid":false,"given":"Min Che","family":"Tung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2021.09.018_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/2042098621997727","article-title":"Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies","volume":"12","author":"Kang","year":"2021","journal-title":"Ther Adv Drug Saf"},{"issue":"5","key":"10.1016\/j.urolonc.2021.09.018_bib0002","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1200\/JCO.19.01395","article-title":"Cancer susceptibility mutations in patients with urothelial malignancies","volume":"38","author":"Carlo","year":"2020","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0003","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.09.018_bib0004","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"10.1016\/j.urolonc.2021.09.018_bib0005","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/0888-7543(91)90163-9","article-title":"Assignment of the human Ki-67 gene (MK167) to 10q25-qter","volume":"11","author":"Fonatsch","year":"1991","journal-title":"Genomics"},{"issue":"Pt 6","key":"10.1016\/j.urolonc.2021.09.018_bib0006","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1242\/jcs.109.6.1253","article-title":"Localisation of the Ki-67 antigen within the nucleolus. Evidence for a fibrillarin-deficient region of the dense fibrillar component","volume":"109","author":"Kill","year":"1996","journal-title":".J Cell Sci"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0007","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.urolonc.2021.09.018_bib0008","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00285178","article-title":"Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10","volume":"83","author":"Schonk","year":"1989","journal-title":"Hum Genet"},{"issue":"Pt 1","key":"10.1016\/j.urolonc.2021.09.018_bib0009","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/jcs.92.1.123","article-title":"Ki-67 detects a nuclear matrix-associated proliferation-related antigen. I. Intracellular localization during interphase","volume":"92","author":"Verheijen","year":"1989","journal-title":"J Cell Sci."},{"issue":"2","key":"10.1016\/j.urolonc.2021.09.018_bib0010","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00412-018-0659-8","article-title":"Ki-67: more than a proliferation marker","volume":"127","author":"Sun","year":"2018","journal-title":"Chromosoma"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0011","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4103\/IJPM.IJPM_588_17","article-title":"Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance","volume":"61","author":"Elkady","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0012","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bju.12263","article-title":"Ki67 is an independent predictor of oncological outcomes in patients with localized clear-cell renal cell carcinoma","volume":"113","author":"Gayed","year":"2014","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2021.09.018_bib0013","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.juro.2014.11.007","article-title":"Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract","volume":"193","author":"Krabbe","year":"2015","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0014","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11255-015-1197-4","article-title":"Prognostic value of Ki67 and p63 expressions in bladder cancer patients who underwent radical cystectomy","volume":"48","author":"Wang","year":"2016","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0015","doi-asserted-by":"crossref","first-page":"e243","DOI":"10.1016\/j.clgc.2015.03.002","article-title":"High Ki-67 expression predicts favorable survival in muscle-invasive bladder cancer patients treated with chemoradiation-based bladder-sparing protocol","volume":"13","author":"Tanabe","year":"2015","journal-title":"Clin Genitourin Cancer"},{"issue":"7","key":"10.1016\/j.urolonc.2021.09.018_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158891","article-title":"Clinicopathological and prognostic value of Ki-67 expression in bladder cancer: a systematic review and meta-analysis","volume":"11","author":"Tian","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0017","doi-asserted-by":"crossref","first-page":"e831","DOI":"10.1016\/j.clgc.2018.02.010","article-title":"Ki-67 as a prognostic marker in upper urinary tract urothelial carcinoma: a systematic review and meta-analysis","volume":"16","author":"Ahn","year":"2018","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2021.09.018_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12885-019-5353-6","article-title":"Cancer-associated fibroblasts induce epithelial-mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling","volume":"19","author":"Goulet","year":"2019","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2021.09.018_bib0019","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/s12967-020-02475-w","article-title":"Practicability of clinical application of bladder cancer molecular classification and additional value of epithelial-to-mesenchymal transition: prognostic value of vimentin expression","volume":"18","author":"Lobo","year":"2020","journal-title":"J Transl Med"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.prp.2018.02.007","article-title":"Prognostic significance of epithelial-mesenchymal transition phenotypes in upper urinary tract urothelial carcinoma","volume":"214","author":"Cho","year":"2018","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.urolonc.2021.09.018_bib0021","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1464-410x.2000.00726.x","article-title":"Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter","volume":"86","author":"Kamai","year":"2000","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2021.09.018_bib0022","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.urolonc.2009.12.003","article-title":"Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract","volume":"30","author":"Scarpini","year":"2012","journal-title":"Urol Oncol"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0023","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00428-014-1541-6","article-title":"Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma","volume":"464","author":"Hayashi","year":"2014","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.urolonc.2021.09.018_bib0024","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4132\/jptm.2015.12.24","article-title":"Korean breast pathology Ki-67 study group. Interobserver variability of Ki-67 measurement in breast cancer","volume":"50","author":"Chung","year":"2016","journal-title":"J Pathol Transl Med"},{"issue":"1","key":"10.1016\/j.urolonc.2021.09.018_bib0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000441525","article-title":"A comparison of the hot spot and the average cancer cell counting methods and the optimal cutoff point of the Ki-67 index for luminal type breast cancer","volume":"90","author":"Arima","year":"2016","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.urolonc.2021.09.018_bib0026","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/dc.23645","article-title":"Use of vimentin immunocytochemical staining for evaluation of atypical cells in voided urine samples","volume":"45","author":"Strojan Fle\u017ear","year":"2017","journal-title":"Diagn Cytopathol"},{"issue":"6","key":"10.1016\/j.urolonc.2021.09.018_bib0027","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1309\/XUVXFXMFPL7TELCE","article-title":"Urine cytology discrepancies: frequency, causes, and outcomes","volume":"127","author":"Raab","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.urolonc.2021.09.018_bib0028","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/s12094-017-1774-3","article-title":"Ki67 targeted strategies for cancer therapy","volume":"20","author":"Yang","year":"2018","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"10.1016\/j.urolonc.2021.09.018_bib0029","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/ejhg.2015.281","article-title":"Genomic complexity of urothelial bladder cancer revealed in urinary cfDNA","volume":"24","author":"Togneri","year":"2016","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"10.1016\/j.urolonc.2021.09.018_bib0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.eururo.2017.09.011","article-title":"Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis","volume":"73","author":"Birkenkamp-Demtr\u00f6der","year":"2018","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921004427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921004427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:24:58Z","timestamp":1761042298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921004427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1078143921004427"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.09.018","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffusive Ki67 and vimentin are associated with worse recurrence-free survival of upper tract urothelial carcinoma: A retrospective cohort study from bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.09.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}